<DOC>
	<DOCNO>NCT02758652</DOCNO>
	<brief_summary>Epithelial ovarian cancer lethal gynecological malignancy develop country fifth common cause cancer-related death woman . Poor prognosis due challenge early diagnosis development inevitable resistance chemotherapy majority patient despite good initial treatment response . The purpose prospective study analyze variation microRNA expression prediction primary treatment response role microRNAs development chemoresistance epithelial ovarian cancer . • Objectives : To screen microRNAs prospectively collect plasma , urine tumor sample patient diagnose epithelial ovarian cancer . Samples analyze microRNA expression differential expression correlate primary treatment response , progression-free survival overall survival . • Methods : Plasma , urine tumor sample collect primary surgery ( open surgery diagnostic laparoscopy ) interval debulking surgery , 1st , 3rd 6th neoadjuvant adjuvant chemotherapy progression high-throughput screen microRNA expression array technology .</brief_summary>
	<brief_title>Molecular Mechanisms Leading Chemoresistance Epithelial Ovarian Cancer</brief_title>
	<detailed_description>Inclusion criterion : patient operate suspected ovarian malignancy Department Obstetrics Gynecology Tampere University Informed consent obtain</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<criteria>18 year age , informed consent . Informed consent provide , age 18 year .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>chemoresistance</keyword>
	<keyword>miRNA</keyword>
	<keyword>microRNA</keyword>
</DOC>